SNPSSynopsys
Synopsys, Inc. (Synopsys, we, our or us) is the leader in engineering solutions from silicon to systems, enabling customers to rapidly innovate AI-powered products. 10-K, Item 1
- Employees
- 28,000
- Headquarters
- Sunnyvale, CA
- CEO
- Sassine Ghazi
- Next results
- around Dec 9, 2026
SNPS and 9 peers, year by year
The 9 Technology companies closest to SNPS in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| SNPS Synopsys | FY2025 | $7.1B | +15.1% | 77.0% | 13.0% | 18.9% | 19.1% | 4.7% | 0.48 |
| MRVL Marvell Technology | FY2026 | $8.2B | +42.1% | 51.0% | 16.1% | 32.6% | 17.0% | 18.7% | 0.35 |
| WDAY Workday, Inc. | FY2026 | $9.6B | +13.1% | - | 7.5% | 7.3% | 29.1% | 8.9% | 0.38 |
| ROP Roper Technologies | FY2025 | $7.9B | +12.3% | 69.2% | 28.3% | 19.4% | - | 7.7% | 0.47 |
| COHR Coherent Corp. | FY2026 | $7.1B | +22.5% | - | - | 11.3% | −14.4% | 7.4% | 0.30 |
| FTNT Fortinet | FY2025 | $6.8B | +14.2% | 80.5% | 30.7% | 27.3% | 32.7% | 149.8% | 0.81 |
| ADSK Autodesk | FY2026 | $7.2B | +17.5% | 91.0% | 21.9% | 15.6% | 33.4% | 36.9% | 0.82 |
| NTAP NetApp | FY2026 | $6.9B | +5.4% | 70.7% | 24.2% | 18.4% | 27.0% | 94.4% | 1.84 |
| PANW Palo Alto Networks | FY2026 | $11.5B | +24.5% | 70.4% | 6.1% | 2.7% | 35.8% | 1.1% | - |
| PLTR Palantir Technologies | FY2025 | $4.5B | +56.2% | 82.4% | 31.6% | 36.3% | 46.9% | 22.0% | - |
Revenue, FY2016 to FY2025
Revenue as reported in the 10-K.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | $2.4B | $2.7B | $3.1B | $3.4B | $3.7B | $4.2B | $5.1B | $5.3B | $6.1B | $7.1B |
| MRVL Jan | - | - | - | - | $2.7B | $3.0B | $4.5B | $5.9B | $5.5B | $5.8B |
| WDAY Jan | $1.2B | $1.6B | $2.1B | $2.8B | $3.6B | $4.3B | $5.1B | $6.2B | $7.3B | $8.4B |
| ROP Dec | $3.8B | $4.6B | $5.2B | $4.7B | $4.0B | $4.8B | $5.4B | $6.2B | $7.0B | $7.9B |
| COHR Jun | $827.2M | $972.0M | $1.2B | $1.4B | $3.1B | - | $3.3B | $5.2B | $4.7B | $5.8B |
| FTNT Dec | $1.3B | $1.5B | $1.8B | $2.2B | $2.6B | $3.3B | $4.4B | $5.3B | $6.0B | $6.8B |
| ADSK Jan | $2.5B | $2.0B | $2.1B | $2.6B | $3.3B | $3.8B | $4.4B | $5.0B | $5.5B | $6.1B |
| NTAP Apr | $5.5B | $5.5B | $5.9B | $6.1B | $5.4B | $5.7B | $6.3B | $6.4B | $6.3B | $6.6B |
| PANW Jul | $1.4B | $1.8B | $2.3B | $2.9B | $3.4B | $4.3B | $5.5B | $6.9B | $8.0B | $9.2B |
| PLTR Dec | - | - | $595.4M | $742.6M | $1.1B | $1.5B | $1.9B | $2.2B | $2.9B | $4.5B |
| Peer median | $1.4B | $1.8B | $2.1B | $2.7B | $3.3B | $4.0B | $4.5B | $5.9B | $6.0B | $6.6B |
Sales growth, FY2016 to FY2025
Revenue against the fiscal year before.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | +8.0% | +12.5% | +14.5% | +7.7% | +9.7% | +14.1% | +20.9% | +15.2% | +15.2% | +15.1% |
| MRVL Jan | - | - | - | - | - | +10.0% | +50.3% | +32.7% | −7.0% | +4.7% |
| WDAY Jan | - | +36.1% | +36.1% | +31.7% | +28.5% | +19.0% | +19.0% | +21.0% | +16.8% | +16.4% |
| ROP Dec | +5.8% | +21.6% | +12.7% | +3.4% | +2.7% | +20.2% | +11.1% | +15.0% | +13.9% | +12.3% |
| COHR Jun | - | +17.5% | +19.2% | +17.6% | +30.5% | - | +6.8% | +55.6% | −8.8% | +23.4% |
| FTNT Dec | +26.4% | +17.2% | +20.5% | +19.9% | +19.9% | +28.8% | +32.2% | +20.1% | +12.3% | +14.2% |
| ADSK Jan | - | −18.9% | +1.3% | +25.0% | +27.4% | +15.8% | +15.7% | +14.1% | +9.8% | +11.5% |
| NTAP Apr | - | −0.5% | +7.8% | +3.8% | −11.9% | +6.1% | +10.0% | +0.7% | −1.5% | +4.9% |
| PANW Jul | - | +27.8% | +29.5% | +27.5% | +17.5% | +24.9% | +29.3% | +25.3% | +16.5% | +14.9% |
| PLTR Dec | - | - | - | +24.7% | +47.2% | +41.1% | +23.6% | +16.7% | +28.8% | +56.2% |
| Peer median | - | +17.5% | +19.2% | +22.3% | +23.7% | +19.6% | +19.0% | +20.1% | +12.3% | +14.2% |
Gross margin, FY2016 to FY2025
Gross profit / revenue.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | 77.6% | 76.0% | 76.4% | 77.6% | 78.4% | 79.5% | 73.2% | 80.6% | 79.7% | 77.0% |
| MRVL Jan | - | - | - | - | 50.3% | 50.1% | 46.3% | 50.5% | 41.6% | 41.3% |
| WDAY Jan | - | - | - | - | - | - | - | - | - | - |
| ROP Dec | 61.5% | 62.2% | 63.2% | 66.4% | 70.3% | 70.5% | 69.9% | 69.7% | 69.3% | 69.2% |
| COHR Jun | - | - | - | - | - | - | - | - | - | - |
| FTNT Dec | 73.5% | 74.2% | 75.0% | 76.6% | 78.0% | 76.6% | 75.4% | 76.7% | 80.6% | 80.5% |
| ADSK Jan | 85.2% | 83.2% | 85.2% | 88.9% | 90.1% | 91.1% | 90.5% | 90.4% | 90.7% | 90.6% |
| NTAP Apr | 60.8% | 61.0% | 62.7% | 64.2% | 66.9% | 66.4% | 66.8% | 66.2% | 70.7% | 70.2% |
| PANW Jul | 73.2% | 72.6% | 71.6% | 72.1% | 70.7% | 70.0% | 68.8% | 72.3% | 74.3% | 73.4% |
| PLTR Dec | - | - | 72.2% | 67.4% | 67.7% | 78.0% | 78.6% | 80.6% | 80.2% | 82.4% |
| Peer median | 73.2% | 72.6% | 71.9% | 69.7% | 70.3% | 70.5% | 69.9% | 72.3% | 74.3% | 73.4% |
Operating margin, FY2016 to FY2025
Operating income / revenue.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | 13.1% | 12.8% | 11.5% | 15.5% | 16.8% | 17.5% | 22.6% | 23.9% | 22.1% | 13.0% |
| MRVL Jan | - | - | - | - | −9.0% | −8.7% | −7.8% | 4.0% | −10.3% | −12.5% |
| WDAY Jan | −21.6% | −22.4% | −14.1% | −16.4% | −13.8% | −5.8% | −2.3% | −3.6% | 2.5% | 4.9% |
| ROP Dec | 27.8% | 26.3% | 26.9% | 28.1% | 26.9% | 25.7% | 28.4% | 28.2% | 28.4% | 28.3% |
| COHR Jun | 11.1% | 11.9% | 11.8% | 10.9% | 12.9% | - | 12.5% | −0.7% | 2.0% | - |
| FTNT Dec | 3.4% | 7.3% | 13.0% | 16.2% | 20.5% | 19.5% | 21.9% | 23.4% | 30.3% | 30.7% |
| ADSK Jan | 0.1% | −24.6% | −24.8% | −1.0% | 10.5% | 16.6% | 14.1% | 19.8% | 20.5% | 22.1% |
| NTAP Apr | 6.3% | 11.3% | 19.6% | 19.9% | 17.5% | 17.9% | 18.3% | 16.0% | 19.4% | 20.3% |
| PANW Jul | −11.4% | −9.4% | −4.6% | −1.9% | −5.3% | −7.1% | −3.4% | 5.6% | 8.5% | 13.5% |
| PLTR Dec | - | - | −104.7% | −77.6% | −107.4% | −26.7% | −8.5% | 5.4% | 10.8% | 31.6% |
| Peer median | 3.4% | 7.3% | 3.6% | 5.0% | 10.5% | 5.4% | 12.5% | 5.6% | 10.8% | 21.2% |
Net margin, FY2016 to FY2025
Net income / revenue.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | 11.0% | 5.0% | 13.9% | 15.8% | 18.0% | 18.0% | 19.4% | 23.1% | 36.9% | 18.9% |
| MRVL Jan | - | - | - | - | 58.7% | −9.3% | −9.4% | −2.8% | −16.9% | −15.3% |
| WDAY Jan | −23.8% | −24.4% | −15.0% | −14.8% | −13.3% | −6.5% | 0.6% | −5.9% | 19.0% | 6.2% |
| ROP Dec | 17.4% | 21.1% | 18.2% | 37.4% | 23.6% | 23.8% | 84.6% | 22.4% | 22.0% | 19.4% |
| COHR Jun | 7.9% | 9.8% | 7.6% | 7.9% | 9.6% | - | 7.1% | −5.0% | −3.3% | 0.8% |
| FTNT Dec | 2.5% | 2.1% | 18.6% | 15.3% | 18.8% | 18.2% | 19.4% | 21.6% | 29.3% | 27.3% |
| ADSK Jan | −13.2% | −28.7% | −27.6% | −3.1% | 6.6% | 31.9% | 11.3% | 16.4% | 16.5% | 18.1% |
| NTAP Apr | 4.1% | 8.7% | 2.0% | 19.0% | 15.1% | 12.7% | 14.8% | 20.0% | 15.7% | 18.0% |
| PANW Jul | −14.0% | −11.5% | −5.4% | −2.8% | −7.8% | −11.7% | −4.9% | 6.4% | 32.1% | 12.3% |
| PLTR Dec | - | - | −97.4% | −78.1% | −106.7% | −33.7% | −19.6% | 9.4% | 16.1% | 36.3% |
| Peer median | 2.5% | 2.1% | −1.7% | 2.5% | 9.6% | 3.1% | 7.1% | 9.4% | 16.5% | 18.0% |
Free cash flow, FY2016 to FY2025
Cash from operations minus capital spending.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | $519.7M | $562.2M | $325.4M | $602.4M | $836.6M | $1.4B | $1.6B | $1.5B | $1.3B | $1.3B |
| MRVL Jan | - | - | - | - | $278.4M | $710.5M | $650.1M | $1.1B | $1.0B | $1.4B |
| WDAY Jan | $125.0M | $229.8M | $324.2M | $404.2M | - | - | - | $1.3B | $1.9B | $2.2B |
| ROP Dec | $926.5M | $1.2B | $1.4B | - | - | - | - | - | - | - |
| COHR Jun | $64.8M | −$19.9M | $7.6M | $41.4M | $428.0M | - | $99.0M | $198.0M | $198.9M | $192.8M |
| FTNT Dec | $278.5M | $459.1M | $585.9M | $715.8M | $957.8M | $1.2B | $1.4B | $1.7B | $1.9B | $2.2B |
| ADSK Jan | - | - | - | $310.1M | $1.4B | $1.3B | $1.5B | $2.0B | $1.3B | $1.6B |
| NTAP Apr | $814.0M | $811.0M | $1.3B | $1.2B | $936.0M | $1.2B | $985.0M | $868.0M | $1.5B | $1.3B |
| PANW Jul | $586.1M | $705.4M | $926.1M | $924.4M | $821.3M | $1.4B | $1.8B | $2.6B | $3.1B | $3.5B |
| PLTR Dec | - | - | −$52.0M | −$178.3M | −$308.8M | $321.2M | $183.7M | $697.1M | $1.1B | $2.1B |
| Peer median | $432.3M | $582.2M | $585.9M | $404.2M | $821.3M | $1.2B | $985.0M | $1.2B | $1.4B | $1.8B |
FCF margin, FY2016 to FY2025
Free cash flow / revenue.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | 21.5% | 20.6% | 10.4% | 17.9% | 22.7% | 33.3% | 31.5% | 28.5% | 20.7% | 19.1% |
| MRVL Jan | - | - | - | - | 10.3% | 23.9% | 14.6% | 18.3% | 18.8% | 24.2% |
| WDAY Jan | 10.8% | 14.6% | 15.1% | 14.3% | - | - | - | 20.8% | 26.4% | 26.0% |
| ROP Dec | 24.4% | 25.7% | 26.6% | - | - | - | - | - | - | - |
| COHR Jun | 7.8% | −2.0% | 0.7% | 3.0% | 13.8% | - | 3.0% | 3.8% | 4.2% | 3.3% |
| FTNT Dec | 21.8% | 30.7% | 32.5% | 33.1% | 36.9% | 36.0% | 32.8% | 32.6% | 31.6% | 32.7% |
| ADSK Jan | - | - | - | 12.1% | 41.6% | 35.5% | 33.6% | 40.6% | 23.3% | 25.6% |
| NTAP Apr | 14.7% | 14.7% | 22.5% | 19.0% | 17.3% | 20.4% | 15.6% | 13.6% | 24.4% | 20.4% |
| PANW Jul | 42.5% | 40.0% | 40.7% | 31.9% | 24.1% | 32.6% | 32.6% | 38.2% | 38.6% | 37.6% |
| PLTR Dec | - | - | −8.7% | −24.0% | −28.3% | 20.8% | 9.6% | 31.3% | 39.8% | 46.9% |
| Peer median | 18.3% | 20.2% | 22.5% | 14.3% | 17.3% | 28.3% | 15.6% | 26.1% | 25.4% | 25.8% |
Return on equity, FY2016 to FY2025
Net income / shareholders' equity at the year end.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | 8.4% | 4.2% | 12.4% | 13.0% | 13.5% | 14.3% | 17.9% | 20.0% | 25.2% | 4.7% |
| MRVL Jan | - | - | - | - | 18.3% | −3.3% | −2.7% | −1.0% | −6.3% | −6.6% |
| WDAY Jan | −22.4% | −30.1% | −20.3% | −21.4% | −19.3% | −8.6% | 0.6% | −6.6% | 17.1% | 5.8% |
| ROP Dec | 11.4% | 14.2% | 12.2% | 18.6% | 9.1% | 10.0% | 28.3% | 7.9% | 8.2% | 7.7% |
| COHR Jun | 8.4% | 10.6% | 8.6% | 9.5% | 8.7% | - | 6.5% | −5.2% | −3.0% | 0.9% |
| FTNT Dec | 3.8% | 5.2% | 32.7% | 24.7% | 57.1% | 77.6% | n/m | n/m | 116.8% | 149.8% |
| ADSK Jan | −20.4% | −79.3% | n/m | n/m | n/m | 125.2% | 58.5% | 71.9% | 48.8% | 42.4% |
| NTAP Apr | 7.9% | 16.3% | 5.1% | 107.2% | n/m | 106.6% | 111.8% | 109.9% | 86.0% | 114.0% |
| PANW Jul | −21.5% | −26.7% | −10.5% | −5.2% | −24.2% | −78.6% | −127.1% | 25.2% | 49.9% | 14.5% |
| PLTR Dec | - | - | n/m | n/m | −76.6% | −22.7% | −14.6% | 6.0% | 9.2% | 22.0% |
| Peer median | 3.8% | 5.2% | 6.8% | 14.1% | 8.7% | 3.3% | 3.6% | 7.0% | 17.1% | 14.5% |
Debt / equity, FY2016 to FY2025
Total debt / shareholders' equity at the year end.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | 0.06 | 0.04 | 0.13 | 0.03 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.48 |
| MRVL Jan | - | - | - | - | - | 0.17 | 0.29 | 0.32 | 0.29 | 0.31 |
| WDAY Jan | - | - | - | - | 0.51 | 0.55 | 0.41 | 0.53 | 0.37 | 0.33 |
| ROP Dec | 1.07 | 0.75 | 0.64 | 0.56 | 0.91 | 0.69 | 0.42 | 0.36 | 0.40 | 0.47 |
| COHR Jun | 0.30 | 0.38 | 0.43 | 0.41 | 0.40 | - | 0.64 | 0.86 | 0.79 | 0.65 |
| FTNT Dec | - | - | - | - | 0.00 | 1.26 | n/m | n/m | 0.67 | 0.81 |
| ADSK Jan | 0.92 | 1.49 | n/m | n/m | n/m | 1.71 | 3.12 | 2.01 | 1.24 | 0.88 |
| NTAP Apr | 0.52 | 0.68 | 0.85 | 1.64 | 6.89 | 3.84 | 3.15 | 2.06 | 2.09 | 3.11 |
| PANW Jul | 0.56 | 0.69 | 1.65 | 0.90 | 2.80 | 5.08 | 17.51 | 1.14 | - | - |
| PLTR Dec | - | - | - | n/m | 0.13 | 0.00 | - | - | - | - |
| Peer median | 0.56 | 0.69 | 0.74 | 0.73 | 0.51 | 0.97 | 0.64 | 0.86 | 0.67 | 0.65 |
EPS (diluted), FY2016 to FY2025
Diluted earnings per share, on today's share count after splits.| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| SNPS Oct | $1.73 | $0.88 | $2.82 | $3.45 | $4.27 | $4.81 | $6.29 | $7.92 | $14.51 | $8.04 |
| MRVL Jan | - | - | - | - | $2.34 | −$0.41 | −$0.53 | −$0.19 | −$1.08 | −$1.02 |
| WDAY Jan | −$1.45 | −$1.94 | −$1.55 | −$1.93 | −$2.12 | −$1.19 | $0.12 | −$1.44 | $5.21 | $1.95 |
| ROP Dec | $6.43 | $9.39 | $9.05 | $16.82 | $8.98 | $10.82 | $42.55 | $12.89 | $14.35 | $14.20 |
| COHR Jun | $1.04 | $1.48 | $1.35 | $1.63 | $2.37 | - | $1.45 | −$2.93 | −$1.84 | −$0.52 |
| FTNT Dec | $0.04 | $0.04 | $0.38 | $0.38 | $0.58 | $0.73 | $1.06 | $1.46 | $2.26 | $2.42 |
| ADSK Jan | −$1.46 | −$2.61 | −$2.58 | −$0.37 | $0.96 | $5.44 | $2.24 | $3.78 | $4.19 | $5.12 |
| NTAP Apr | $0.77 | $1.71 | $0.42 | $4.51 | $3.52 | $3.23 | $4.09 | $5.79 | $4.63 | $5.67 |
| PANW Jul | −$0.37 | −$0.37 | −$0.22 | −$0.14 | −$0.46 | −$0.86 | −$0.45 | $0.64 | $3.64 | $1.60 |
| PLTR Dec | - | - | −$1.17 | −$1.02 | −$1.20 | −$0.27 | −$0.18 | $0.09 | $0.19 | $0.63 |
| Peer median | $0.04 | $0.04 | $0.08 | $0.12 | $0.96 | $0.23 | $1.06 | $0.64 | $3.64 | $1.95 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out SNPS and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →
Work on SNPS in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/SNPS/export.csv") into a cell.